ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N06AX27 | B | Esketamine - 28mg/device | 10524 | 81820/1 | SPRAVATO | 28mg/device | 1 | Solution | Nasal | Mersaco | Renaissance Lakewood LLC | USA | 26,418,709 L.L | 19.35 | D | Janssen Cilag International NV | Belgium | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N06AX27 | B | Esketamine (HCl) - 28mg | 11709 | 82020/1 | SPRAVATO | 28mg/device | 3 | Solution | Nasal | Mersaco | Renaissance Lakewood LLC | USA | 66,978,978 L.L | 10.71 | E1 | Janssen Cilag International NV | Belgium | 2/5/2024 | 0 |